Form 4: Ekso Bionics Director, Corinna Lathan, Reports Acquisition of Restricted Stock Units

Director Corinna Lathan reports acquisition of 236,202 restricted stock units (RSUs) in Ekso Bionics Holdings, Inc. following the company's annual meeting.

Summary

• Corinna Lathan, a director of Ekso Bionics Holdings, Inc., filed a Form 4 on May 19, 2025, reporting a transaction that occurred on May 16, 2025.
• Lathan acquired 236,202 restricted stock units (RSUs) at a price of $0.
• These RSUs were granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders.
• The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
• Following the reported transaction, Lathan beneficially owns 462,409 shares of common stock, including 236,202 unvested RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by a director is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction related to director compensation.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.

Industry Context

This filing is a routine disclosure related to director compensation and aligns with standard corporate governance practices.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Form 4, EKSO, Ekso Bionics, Director, Corinna Lathan, Restricted Stock Units, RSUs, Beneficial Ownership, Annual Meeting